Invesco Ltd. - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 272 filers reported holding 10X GENOMICS INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.6%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$91,841,724
-12.1%
2,226,466
+18.9%
0.02%
-7.4%
Q2 2023$104,520,529
+12.3%
1,871,786
+12.2%
0.03%
+3.8%
Q1 2023$93,038,918
+3202.6%
1,667,663
+2057.2%
0.03%
+2500.0%
Q4 2022$2,817,104
-24.4%
77,308
-40.9%
0.00%0.0%
Q3 2022$3,727,000
-35.8%
130,878
+1.9%
0.00%
-50.0%
Q2 2022$5,809,000
-43.0%
128,396
-4.2%
0.00%
-33.3%
Q1 2022$10,200,000
-62.2%
134,091
-26.0%
0.00%
-57.1%
Q4 2021$26,993,000
-66.4%
181,210
-67.2%
0.01%
-65.0%
Q3 2021$80,310,000
-66.1%
551,656
-54.4%
0.02%
-65.5%
Q2 2021$236,640,000
+0.3%
1,208,454
-7.3%
0.06%
-7.9%
Q1 2021$235,904,000
+50.8%
1,303,332
+17.9%
0.06%
+37.0%
Q4 2020$156,484,000
-30.0%
1,105,115
-38.4%
0.05%
-39.5%
Q3 2020$223,530,000
+90.4%
1,792,833
+36.4%
0.08%
+81.0%
Q2 2020$117,395,000
+50.1%
1,314,467
+4.7%
0.04%
+27.3%
Q1 2020$78,213,000
+120.9%
1,255,022
+170.3%
0.03%
+200.0%
Q4 2019$35,399,000
+94.8%
464,253
+28.7%
0.01%
+120.0%
Q3 2019$18,174,000360,5920.01%
Other shareholders
10X GENOMICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 708,528$29,226,780100.00%
Meritech Capital Associates V L.L.C. 494,236$20,387,2356.48%
Sands Capital Ventures, LLC 481,770$19,873,0135.88%
Decheng Capital Management III (Cayman), LLC 359,554$14,831,6034.95%
Iron Triangle Partners LP 666,945$27,511,4814.02%
Endurant Capital Management LP 71,044$2,930,5652.63%
Brown Capital Management 3,081,105$127,095,5811.95%
RTW INVESTMENTS, LP 1,519,956$62,698,1851.32%
Parametrica Management Ltd 15,300$631,1251.06%
Capital Impact Advisors, LLC 14,821$611,3661.02%
View complete list of 10X GENOMICS INC shareholders